Ethnic disparities in the incidence, presentation and complications of malignant hypertension

Journal of Hypertension

Volumn 24, Issue 11, 2006, Pages 2299-2304

  Van Den Born, Bert Jan H ^a   Koopmans, Richard P ^a   Groeneveld, Johan O ^b   Van Montfrans, Gert A ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

Author keywords

Blacks; Ethnicity; Malignant hypertension; Renal insufficiency

Indexed keywords

ANTIHYPERTENSIVE AGENT; CREATININE;

ADULT; AGE DISTRIBUTION; ARTICLE; BLOOD PRESSURE REGULATION; BRAIN INFARCTION; CAUCASIAN; CONFIDENCE INTERVAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; ETHNIC DIFFERENCE; FEMALE; HEALTH INSURANCE; HOSPITAL ADMISSION; HUMAN; INCIDENCE; KIDNEY DYSFUNCTION; KIDNEY FAILURE; LEUKOENCEPHALOPATHY; MAJOR CLINICAL STUDY; MALE; MALIGNANT HYPERTENSION; NEGRO; NETHERLANDS; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; SEX RATIO; SYSTOLIC BLOOD PRESSURE; TREATMENT WITHDRAWAL;

EID: 33750235172     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.hjh.0000249710.21146.38     Document Type: Article

References (16)

1. Keith NM, Wagener HP, Barker NW. Some different types of essential hypertension: their course and prognosis. Am J Med Sci 1939; 196:332-343.
2. Gudbrandsson T. Malignant hypertension. A clinical follow-up study with special reference to renal and cardiovascular function and immunogenetic factors. Acta Med Scand Suppl 1981; 650:1-62.
3. Lip GY, Beevers M, Beevers G. The failure of malignant hypertension to decline: a survey of 24 years' experience in a multiracial population in England. J Hypertens 1994; 12:1297-1305.
4. Scarpelli PT, Livi R, Caselli GM, Di Maria L, Teghini L, Montemurro V, et al. Accelerated (malignant) hypertension: a study of 121 cases between 1974 and 1996. J Nephrol 1997; 10:207-215.
5. Agyemang C, Bindraban N, Mairuhu G, Montfrans G, Koopmans R, Stronks K. Prevalence, awareness, treatment, and control of hypertension among Black Surinamese, South Asian Surinamese and White Dutch in Amsterdam, the Netherlands: the SUNSET study. J Hypertens 2005; 23:1971-1977.
6. Veriava Y, du TE, Lawley CG, Milne FJ, Reinach SG. Hypertension as a cause of end-stage renal failure in South Africa. J Hum Hypertens 1990; 4:379-383.
7. Shea S, Misra D, Ehrlich MH, Field L, Francis CK. Predisposing factors for severe, uncontrolled hypertension in an inner-city minority population. N Engl J Med 1992; 327:776-781.
8. Isaacson C, Milne FJ, van Niekerk I, Kenyon MR, Mzamane DV. The renal histopathology of essential malignant hypertension in black South Africans. S Afr Med J 1991; 80:173-176.
9. Opie LH, Seedat YK. Hypertension in sub-Saharan African populations. Circulation 2005; 112:3562-3568.
10. Isles CG. Malignant hypertension and hypertensive encephalopathy. In: Swales JD, editor. Textbook of hypertension. Oxford, UK: Blackwell Scientific Publishers; 1994.
11. van den Born BJ, Honnebier UP, Koopmans RP, van Montfrans GA. Microangiopathic hemolysis and renal failure in malignant hypertension. Hypertension 2005; 45:246-251.
12. Ahmed ME, Walker JM, Beevers DG, Beevers M. Lack of difference between malignant and accelerated hypertension. BMJ (Clin Res) 1986; 292:235-237.
13. Guerin C, Gonthier R, Berthoux FC. Long-term prognosis in malignant or accelerated hypertension. Nephrol Dial Transplant 1988; 3:33-37.
14. Kadiri S, Olutade BO. The clinical presentation of malignant hypertension in Nigerians. J Hum Hypertens 1991; 5:339-343.
15. Lip GY, Beevers M, Beevers DG. Complications and survival of 315 patients with malignant-phase hypertension. J Hypertens 1995; 13:915-924.
16. Webster J, Petrie JC, Jeffers TA, Lovell HG. Accelerated hypertension - patterns of mortality and clinical factors affecting outcome in treated patients. Q J Med 1993; 86:485-493.